Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.
Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determinate the AMH levels before and after antiviral therapy
with Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir in comparison with age-matched
HCV-positive women not undergoing antiviral treatment.